NCT04373369 2025-11-03Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung CancerWashington University School of MedicinePhase 2 Terminated11 enrolled 10 charts
NCT03583086 2024-10-08Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic TumorsVanderbilt-Ingram Cancer CenterPhase 1/2 Completed88 enrolled 20 charts